Heart Failure & Cor Pulmonale & A-fib/flutter Flashcards

1
Q

_____ x ______ = cardiac output

A

stroke volume x heart rate = CO (amount of blood your heart can beat in 1 min (mL/min)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is stroke volume determined by

A

preload, afterload, and ventricular contractility (SV = EDV-ESV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the Frank-Starling law

A
  • greater EDV increases contractile strength of the ventricles which increases SV
  • myocardium will be more stretched d/t greater volume which leads to stronger contraction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does the sympathetic nervous system maintain cardiac output

A

improves ventricular contractility and HR, systemic arteriolar vasoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how does the RAAS system maintain cardiac output

A
  • increased angiotensin II, vasoconstrictor that attempts to maintain an adequate BP
  • increased aldosterone, hormone that increases plasma volume to maintain adequate ventricular filling (preload)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how does ADH secretion maintain cardiac output

A

increases ventricular filling (preload) by decreasing water excretion in the urine & increasing thirst

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the downside of the SNS, RAAS, and ADH secretion maintaining cardiac output in the context of heart failure long term?

A

structural changes to the heart that are damaging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When is natriuretic peptide released and what can it tell us in the workup for HF (BNP & NT-proBNP labs)

A
  • released d/t stretching of ventricular walls or increased pressure upon the walls
  • in HF this increases water and sodium excretion in the urine
  • serial BNP levels to guide management of acute HF not established & should not be used in isolation to exclude or confirm HF (high negative predictive value)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the etiology of heart failure

A

heart unable to pump enough blood to meet body’s need for O2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the most common cause of left sided heart failure

A

CAD (then dilated CMO, restrictive CMO, & hypertrophic CMO)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the most common cause of R sided HF

A

L sided HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the major types of HF

A
  • HFrEF: EF <40%
  • HFpEF: EF >50%
  • HFimpEF: EF previously <40% but now greater
  • HFmrEF: EF 41-49%
  • high output HF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the major RFs for HF

A

CAD, HTN, DM, valvular disease, smoking, obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the major signs/symptoms of HF

A

Fatigue, weakness, dyspnea on exertion, cough, orthopnea, paroxysmal nocturnal dyspnea, GI sxs, weight gain, LE edema

Labored breathing, need to sit upright, sinus tach (increased adrenergic activity), peripheral vasoconstriction (cool extremities, cyanosis of lips & nail beds)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the diagnostic testing for HF

A

EKG: may see acute ischemia as cause of new-onset HF, may provide info about etiology of HF (arrhythmia, LVH), low specificity

Labs: CBC, CMP (renal fx, electrolytes - Na & K, liver enzymes), cardiac enzymes, brain or B-type natriuretic peptide (BNP) and N-terminal BNP (NT-proBNP)

CXR: helpful in identifying cardiac v pulmonary etiology, signs of acute decompensated HF include cardiomegaly, pleural effusion, interstitial edema (Kerley B lines), cephalization of vessels (upper lobe vessels larger than lower lobe vessels)

Echo: assess size & function of chambers, valves, pericardial effusion, shunting & regional wall motion, segmental wall abnormalities, determines LV EF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the etiology/causes of cor pulmonale

A

Pulmonary HTN induced altered structure (hypertrophy or dilation) and/or impaired fx of R ventricle associated with chronic lung disease/hypoxemia

Pulmonary HTN related to lung disease increases RV afterload & can lead to R heart failure

Causes: COPD, PE, CF, interstitial lung dz, pneumoconiosis

R heart failure d/t pulm dz

17
Q

Describe the clinical presentation of cor pulmonale

A

Dyspnea, orthopnea & PND rarely sxs of isolated RF, tussive or effort related syncope d/t inability of RV to deliver blood to L side, sxs of right HF

Ascites, peripheral edema

18
Q

Describe the treatment for cor pulmonale

A

Treat underlying pulm dz

Oxygenation >90-92%

Diuretics effective in treating volume overload d/t right HF

Pulmonary vasodilators

19
Q

Describe the 4 major types of A-fib

A

Paroxysmal: starts spontaneously & stops within 7 days

Persistent: duration 7+ days

Long-standing persistent: 1+ year

Permanent: persistent AF who have made decision with provider to stop attempts to control rhythm

20
Q

Describe the sxs of a-fib

A

asymptomatic, fatigue, palpitations, lightheadedness, SOB, chest pain, anxiety, reduced exercise capacity, stroke

21
Q

Describe the etiology of a-fib

A

Rapid firing ectopic foci mainly from pulmonary veins that overrides the SA nodes, AV node receives 500+ and allows only some to pass (120-180 bpm)

Impaired atrial contraction - decreased preload & CO - remodeling of atrium (less likely to spontaneously return to NSR)

22
Q

Describe the two major categories of a-fib treatment (technically 3)

A

Rhythm control:
- cardioversion (required in persistent AF, preferred in symptomatic paroxysmal, urgent if unstable)
- antiarrhythmic drugs: propafenone, flecainide, amiodarone (Many AEs)
- catheter ablation (1st or after AAD)

Rate control:
- B-blocker: metoprolol
- Non-DHP Ca Channel blocker: diltiazem, verapamil
- can add digoxin if not effective

Anticoag:
- Vit K antagonist (Warfarin)
- Direct acting: Factor Xa (Xarelto, Eliquis), antithrombin inhibitor (Pradaxa)

23
Q

Describe the EKG of a-fib

A

irregularly irregular appearance of QRS complex, absence of discrete P waves

24
Q

Describe the EKG of a-flutter

A

atrial rate 250-350 bpm, often conducts to ventricles with 2:1 AV block creating a regularly tachy at 150 bpm, atrial “sawtooth”

25
Q

Describe the CHADS(2) VASc score

A

Thromboembolic risk